Perinatally acquired bacterial sepsis: Analysis of a new approach, are we on the right tract? 1st part: Early detection of group B streptococcal infection;Infection bactérienne néonatale par contamination materno-fœtale: Pour un changement de paradigme? 1re partie: Dépistage de l'infection à Streptococcus agalactiae: Modalités et bilan des effets

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 30, Issue 6, 2001, Pages 521-531

  Blond, M H ^a   Gold, F ^a   Pierre, F ^a   Quentin, R ^a   Aujard, Y ^a  

^a Centre de Pediatrie Clocheville   (France)

Author keywords

Antenatal screening; Group B Streptococci; Neonatal sepsis; Perinatal infection; Prophylactic antibiotics in obstetrics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLAVULANIC ACID; ERYTHROMYCIN; PENICILLIN V; PRISTINAMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; FETUS RISK; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; NEWBORN SEPSIS; PERINATAL INFECTION; PERINATAL MORTALITY; PRACTICE GUIDELINE; REVIEW; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0034783539     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Infection bactérienne materno-fœtale. Éditions techniques
2. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease
3. Prevention of perinatal group B streptococcal disease: A Public Health perspective
4. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
5. Prevention of early-onset neonatal group B streptococcal disease
6. Revised guidelines for prevention of early-onset group B Streptococcal (GBS) infection
7. Opportunities for prevention of perinatal group B streptococcal disease: A multistate surveilance analysis
8. Intrapartum management relating to the risk of perinatal transmission of group B streptococcus
9. Prevention of perinatal group B streptococcal infection: Adressing current controversies
10. Streptococcus agalactiae
11. Prélèvements vaginaux et endocervicaux: Quand et comment les réaliser?
12. Risk factors for early-onset group B streptococcal sepsis: Estimation of odds ratios by critical literature review
13. Quels sont les risques liés aux portages vaginaux et aux infections génitales basses pour la mère, le fœtus et le nouveau-né?
14. Group B streptococci: Results of a protocol of antepartum screening and intrapartum treatment
15. Epidemiology of group B streptococcus: Longitudinal observations during pregnancy
16. Selective intrapartum chemoprophylaxis of neonatal goup B streptococcal early-onset disease. II. Predictive value of prenatal cultures
17. Perinatal goup B streptococcal colonization and infection
18. Maternal carriage and neonatal acquisition of group B streptococci
19. Untersuchungen zur häufigkeit von B streptokokken erkrankungen und besiedelung-eine klinish epidemiologische studie
20. Colonization with group B streptococci in pregnancy and adverse outcome
21. Maternal carriage of group B streptococci in developing countries
22. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development
23. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis
24. Risk factors for neonatal sepsis
25. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization
26. Group B streptococcal colonization patterns in mothers and in their infants
27. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour
28. Conduite ȧ tenir face à une colonisation materno-infantile à streptocoques du groupe B
29. Assessment of rapid identification tests for genital carriage of streptococci
30. Evaluation of a rapid latex test for direct detection of streptococcus agalactiae in various obstetrical and gynaecologic disorders
31. Value of rapid enzyme-linked immunoabsorbent assay for maternal vaginal group B strreptococcus colonization
32. Assessment of two methods for rapid intrapartum detection of vaginal group B streptococcal colonisation
33. Prevention of early onset group B streptococcal sepsis in the newborn
34. Outcome of the vaginal infections and prematurity study: Results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci
35. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III
36. Prevention of early-onset group B streptococcal disease with selective intrapartum chemoprophylaxis
37. Prevention of early-onset group B Streptococcal disease in newborns
38. Adoption of hospital policies for prevention of perinatal group B streptococcal disease-United States, 1997
39. Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis
40. Hospital-based policies for prevention of perinatal group B streptococcal Disease-United States, 1999
41. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis
42. Ampicillin for neonatal group B streptococcal prophylaxis: How rapidly can bactericidal concentrations be achieved?
43. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus
44. Selective intrapartum prophylaxis for group B streptococcus colonization: Management and outcome of newborns
45. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis
46. Antimicrobial prevention of early-onset group B Streptococcal sepsis: Estimates of risk reduction based on a critical literature review
47. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study
48. Broad-spectrum antibiotics for spontaneous preterm labour: The ORACLE II randomised trial
49. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: The ORACLE I randomised trial
50. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin
51. Potential consequences of widespread antepartal use of ampicillin
52. Antibiotic use in pregnancy and drug-resistant infant sepsis
53. Traitement des infections néonatales: La place des céphalosporines
54. Antibiothérapie et infection materno-fœtale
55. Les infections du nouveau-né: Aspect clinique et traitement
56. Epidémiologie bactérienne de l'infection materno-fœtale: Expérience d'un centre périnatal
57. Les défenses anti-infectieuses. L'infection bactérienne néonatale
58. Infection nosocomiale en périnatologie: Point de vue néonatal
59. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit
60. An antibiotic policy to prevent emergence of resistant bacilli
61. Acquisition de la flore intestinale néonatale: Rôle sur la morbidité et perspectives thérapeutiques
62. Nosocomial infections among neonates in high-risk nurseries in the United States
63. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units
64. Nosocomial infections in pediatric patients: A European, multicenter prospective study
65. Antibiothérapie en maternité: Importance d'une utilisation rationnelle